MiNK Therapeutics, Inc. (INKT) Social Stream



MiNK Therapeutics, Inc. (INKT): $2.19

-0.10 (-4.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add INKT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 439

in industry

MINK THERAPEUTICS INC (INKT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering INKT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 4 $30 $24 $26.666 $2.29 1064.45%
2022-03-21 4 $30 $10 $22 $2.29 860.7%
2022-05-11 4 $30 $7 $21 $2.29 817.03%
2022-11-06 5 $30 $7 $17.5 $2.29 664.19%
2022-11-14 3 $7 $7 $7 $2.29 205.68%

INKT reports an average of 796.17% for its upside potential over the past 34 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-11 5 30 7 21.0 1.29 1527.91%
2022-05-11 4 30 7 21.0 1.29 1527.91%
2022-11-03 5 30 7 17.5 2.25 677.78%
2022-11-06 5 7 7 7.0 2.44 186.89%
2022-11-06 5 30 7 17.5 2.44 617.21%

INKT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


INKT's average broker recommendation rating improved by 0 over the prior 35 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, MINK THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 653.8% of them.
  • MINK THERAPEUTICS INC's variance in analysts' estimates is lower than -278.81% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, MINK THERAPEUTICS INC's number of analysts covering the stock is higher than 164.51% of them.
  • MINK THERAPEUTICS INC's average analyst price target is greater than 213.03% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MINK THERAPEUTICS INC are AURA, CMPX, and VIGL.

What is the outlook for INKT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7131 seconds.